首页> 外国专利> METHOD FOR EVALUATION OF SENSITIVITY OF CANCER TISSUE DERIVED CELL MASS OR AGGREGATED CANCER CELL MASS TO MEDICINAL AGENT OR RADIOACTIVE RAY

METHOD FOR EVALUATION OF SENSITIVITY OF CANCER TISSUE DERIVED CELL MASS OR AGGREGATED CANCER CELL MASS TO MEDICINAL AGENT OR RADIOACTIVE RAY

机译:评估癌组织源性或聚集性癌细胞对药物或放射线敏感性的方法

摘要

in vivoin vitroDisclosed is a method for evaluating the sensitivity to a medicinal agent or a radioactive ray using a novel cancer tissue derived cell mass or aggregated cancer cell mass which can reflect the behavior of cancer cells accurately. Firstly the cancer tissue derived cell mass or aggregated cancer cell mass is prepared from an individual. The evaluation is achieved by applying a medicinal agent or a radioactive ray to the novel cancer tissue derived cell mass or aggregated cancer cell mass and evaluating the state of growth of the cancer tissue derived cell mass or aggregated cancer cell mass determining whether the cancer tissue derived cell mass or aggregated cancer cell mass is dead or alive or analyzing a signal from the cancer tissue derived cell mass or aggregated cancer cell mass.
机译:体内公开了一种使用新的癌组织衍生的细胞团或聚集的癌细胞团来评估药物对药物或放射线敏感性的方法,该细胞团或聚集的癌细胞团可以准确反映癌细胞的行为。首先,从个体制备癌组织来源的细胞团或聚集的癌细胞团。通过将药物或放射性射线施加到新的癌组织衍生的细胞团或聚集的癌细胞团并评估癌组织衍生的细胞团或聚集的癌细胞团的生长状态来确定该癌组织是否衍生来实现评估。细胞团或聚集的癌细胞团死亡或存活,或分析来自癌组织的细胞团或聚集的癌细胞团的信号。

著录项

  • 公开/公告号IN2012CN09815A

    专利类型

  • 公开/公告日2015-01-02

    原文格式PDF

  • 申请/专利权人

    申请/专利号IN9815/CHENP/2012

  • 发明设计人 INOUE MASAHIRO;

    申请日2012-11-21

  • 分类号G01N33/15;G01N33/50;

  • 国家 IN

  • 入库时间 2022-08-21 15:15:09

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号